Overview

A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
4-month study including a 30-day baseline phase
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA